News

The US Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized COVID-19 restrictions ...
By Dennis Thompson HealthDay ReporterTUESDAY, May 6, 2025 (HealthDay News) -- The head of the U.S. Food and Drug ...
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
From sowing doubt about childhood vaccines to appointing fringe researchers to lead bogus studies, Kennedy is advancing the ...
“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...
The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.
Because the coronavirus continually mutates, manufacturers follow instructions from FDA to make one change each year to their recipe — which strain to target — just like flu vaccines.
Moderna MRNA kicked off 2025 with mixed first-quarter results. While its streamlining efforts improved bottom-line numbers, ...
The FDA chief has called into question whether the agency will approve and authorize the COVID-19 vaccine for winter. In August 2024, the U.S. Food and Drug Administration approved the updated ...